Navigation Links
Matrix Detachable Coils

ProductsMatrix Detachable Coils
Company Boston Scientific Corporation
Item Matrix Detachable Coils
Features Copolymer-Platinum Construction:
  • Matrix Coils are platinum coils covered with an absorbable copolymer. Approximately 70% of the coil volume is comprised of the absorbable copolymer which is typically absorbed by the body within 90 days.

  • Absorbable Copolymer:
  • Matrix Coils employ a well-characterized Polyglycolic-Polylactic Acid (PGLA) copolymer that has been used in many biocompatible devices, such as surgical staples, orthopedic implants, sutures, and drug delivery vehicles.

  • Motion-Free Detachment:
  • Matrix Coils utilize electrolytic detachment for coil delivery. Because the electrolytic process does not rely on mechanical movement to deliver the coil, it provides precise, motion-free detachment.

  • Matrix Coil Construction:
  • Matrix Coils employ a proprietary outer copolymer coil over an inner platinum main coil. The copolymer runs the entire length of the main coil and constitutes approximately 70% of total coil volume.

  • Fluoroscopic Visualization:
  • The platinum main coil provides for fluoroscopic visualization. Image (below): 12-month follow-up angiography of a basilar tip aneurysm -- 11 x 9 mm dome; 4 mm neck; 11 coils -- shows a complete obliteration. Published with permission from A.K. Wakhloo, MD, University of Miami, Jackson Memorial Hospital.**

  • Lubricious Coating:
  • A lubricious coating on the surface of the outer copolymer coil facilitates coil deployment and retraction when wet.
  • Description Aneurysm occlusion is the ultimate objective of neurovascular treatment with conventional bare platinum coils. With Matrix Detachable Coils, occlusion is only the beginning...

    Matrix Detachable Coils are intended for embolization of those intracranial aneurysms that -- because of their morphology, their location, or the patient's general medical condition -- are considered by the treating neurosurgical team to be a) very high risk for management by traditional operative techniques, or b) inoperable. Matrix Coils are also intended for embolization of other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. Matrix Coils are also intended for arterial and venous embolizations in the peripheral vasculature.

    Our proven stretch-resistant technology is designed to virtually eliminate stretching during positioning and repositioning of the coil prior to deployment.* Stretch-resistant coils are engineered for enhanced delivery, and are now available in 2D Standard SR as well as 2D Soft SR and UltraSoft SR. Five softness grades: Extra-Firm, Firm, Standard, Soft, and UltraSoft, provide for a range of vessel morphologies. An extensive choice of coil designs and sizes provide the physician with 89 treatment options. Matrix Detachable Coils are compatible with the Excelsior SL-10, Excelsior 1018, and Tracker Excel-14 microcatheters. Note: Matrix Extra Firm are not compatible with the Excelsior SL-10 microcatheter.
    Info Boston Scientific Corporation
    Customer Service: (888) 272-1001
    Web site: http://www.bostonscientific.com

    Related medicine products :

    1. Humphrey Matrix
    2. Duragen Dural Graft Matrix
    3. Grafton DBM Matrix PLF
    4. DBX Demineralized Bone Matrix
    5. Surgisis® IHM™ Inguinal Hernia Matrix
    6. Matrix Acrylic IOL
    7. Humphrey Matrix Perimeter
    8. Pelvicol Acellular Collagen Matrix (Continence)
    9. Pelvicol® Acellular Collagen Matrix
    10. Hydrix XM Collagen Matrix
    11. Repliform® Tissue Regeneration Matrix
    ... Q Fever IFA Test Kits for the ... human antibody responses to Coxiella burnetii. Our ... semi-quantitative detection and differentiation of antibodies to ... antigens. By providing the two phases, Focus ...
    ... Indirect immunofluorescent antibody (IFA) test for the ... antibodies to St. Louis Encephalitis (SLE), Western ... and California Encephalitis/La Crosse (CE) group viruses. ... fixed individual spots of SLE, WEE, EEE, ...
    ... Indirect immunofluorescent antibody (IFA) test ... human serum IgG antibodies to the ... antibodies to Epstein-Barr virus early antigens, ... Each kit contains ten 12-well slides, ...
    ... the treatment of nonunions, failed fusions, and ... Overview , EBI is the ... growth stimulators , Introduced in 1979 as ... , Indicated for nonunion fractures, failed fusions ...
    Medicine Products:
    (Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
    (Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
    (Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Farm ... California Berkeley, and other leading institutions in announcing the launch of the ... change the way animals are raised for food. , Founding members of the ...
    Breaking Medicine News(10 mins):
    (Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
    (Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
    (Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
    Breaking Medicine Technology: